Cargando…
Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
Patients with type 2 diabetes mellitus are at risk for accelerated cognitive decline and dementia. Furthermore, their risk of stroke is increased and their outcome after stroke is worse than in those without diabetes. Incretin‐based therapies are a class of antidiabetic agents that are of interest i...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718099/ https://www.ncbi.nlm.nih.gov/pubmed/26816596 http://dx.doi.org/10.1111/jdi.12420 |